NIKKEI 225
38,266.30 -7.75 (-0.02%) HANG SENG
18,178.99 +415.96 (+2.34%) CRUDE OIL
79.47 +0.47 (+0.59%) GOLD FUTURES
2,324.30 +13.30 (+0.58%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,797.58 -2,041.51 (-4.27%)
LLY Jan 2025 195.000 put
| Previous close | 0.2500 |
| Open | 0.2500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 195.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.2500 - 0.2500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Yahoo Finance3 stocks with the biggest gains took April's biggest losses
The stock market's very rough April saw some of the biggest gainers of the first three months take some of the biggest dings to their market caps. And at the same time, some of the sectors that struggled in Q1 saw a similar reversal of fortune in April.
ReutersObesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast
LONDON (Reuters) -Novo Nordisk raised its 2024 outlook on Thursday as it posted first-quarter operating profit above analyst forecasts. Novo said it now expects sales growth this year of between 19% and 27% in local currencies, compared to the previously guided range for 18% to 26% growth.
- Reuters
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain just months after the weight-loss drugs were launched there, as initial supply shortages ease. But growing competition between retailers has raised fears that some patients who buy the drugs themselves, rather than relying on the National Health Service (NHS), will miss out on long-term aftercare if they keep switching providers.
